Emily C Dowling
Overview
Explore the profile of Emily C Dowling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi J, Nipp R, Tramontano A, Ali A, Zhan T, Pandharipande P, et al.
Oncologist
. 2018 Dec;
24(7):945-954.
PMID: 30559125
Background: The effectiveness and cost-effectiveness of using neoadjuvant FOLFIRINOX (nFOLFIRINOX) for patients with borderline resectable or locally advanced pancreatic ductal adenocarcinoma (BR/LA PDAC) are unknown. Our objective was to determine...
2.
Kent E, Davidoff A, de Moor J, McNeel T, Virgo K, Coughlan D, et al.
J Psychosoc Oncol
. 2018 Apr;
36(3):287-303.
PMID: 29634413
Background: We examined the longitudinal association between sociodemographic factors and an expanded definition of underemployment among those with and without cancer history in the United States. Methods: Medical Expenditure Panel...
3.
Nipp R, Tramontano A, Kong C, Pandharipande P, Dowling E, Schrag D, et al.
Cancer Med
. 2018 Jan;
7(2):525-535.
PMID: 29322643
Age, sex, and racial/ethnic disparities exist, but are understudied in pancreatic adenocarcinoma (PDAC). We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database to determine whether survival and treatment...
4.
Tramontano A, Sheehan D, Yeh J, Kong C, Dowling E, Rubenstein J, et al.
Am J Gastroenterol
. 2017 Apr;
112(8):1256-1264.
PMID: 28374815
Objectives: Endoscopic surveillance of patients with Barrett's Esophagus (BE) is recommended to detect esophageal adenocarcinoma (EAC) and its dysplasia precursors, but survival benefits are unclear. Using Surveillance, Epidemiology, and End...
5.
Heberle C, Omidvari A, Ali A, Kroep S, Kong C, Inadomi J, et al.
Clin Gastroenterol Hepatol
. 2017 Feb;
15(9):1397-1404.e7.
PMID: 28238953
Background & Aims: It is important to identify patients with Barrett's esophagus (BE), the precursor to esophageal adenocarcinoma (EAC). Patients with BE usually are identified by endoscopy, which is expensive....
6.
Eisenberg J, Reisner A, Binder W, Zaheer A, Gunn M, Linnau K, et al.
AJR Am J Roentgenol
. 2017 Jan;
208(3):570-576.
PMID: 28075619
Objective: The objective of our study was to determine whether specific patient and physician factors-known before CT-are associated with a diagnosis of nonspecific abdominal pain (NSAP) after CT in the...
7.
Pandharipande P, Alabre C, Coy D, Zaheer A, Miller C, Herring M, et al.
Radiology
. 2016 Aug;
281(3):835-846.
PMID: 27479641
Purpose To determine the effect of computed tomography (CT) results on physician decision making in three common clinical scenarios in primary care. Materials and Methods This research was approved by...
8.
de Moor J, Dowling E, Ekwueme D, Guy Jr G, Rodriguez J, Virgo K, et al.
J Cancer Surviv
. 2016 Jul;
11(1):48-57.
PMID: 27423439
Purpose: Previous research describing how informal cancer caregiving impacts employment has been conducted in small samples or a single disease site. This paper provides population-based estimates of the effect of...
9.
Tramontano A, Sheehan D, McMahon P, Dowling E, Holford T, Ryczak K, et al.
BMJ Open
. 2016 Mar;
6(2):e010227.
PMID: 26928026
Objective: While the US Preventive Services Task Force has issued recommendations for lung cancer screening, its effectiveness at reducing lung cancer burden may vary at local levels due to regional...
10.
Pandharipande P, Jeon A, Heberle C, Dowling E, Kong C, Chung D, et al.
EBioMedicine
. 2016 Feb;
2(12):1980-6.
PMID: 26844277
Background: BRCA2 mutation carriers are at increased risk for multiple cancers including pancreatic adenocarcinoma (PAC). Our goal was to compare the effectiveness of different PAC screening strategies in BRCA2 mutation...